KILITCH DRUGS (INDIA) LTD.

NSE : KILITCHBSE : 524500ISIN CODE : INE729D01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE347.80-3.35 (-0.95 %)
PREV CLOSE ( ) 351.15
OPEN PRICE ( ) 342.70
BID PRICE (QTY) 347.80 (7)
OFFER PRICE (QTY) 350.95 (1)
VOLUME 1037
TODAY'S LOW / HIGH ( )340.35 353.80
52 WK LOW / HIGH ( )157 469.85
NSE348.50-2.4 (-0.68 %)
PREV CLOSE( ) 350.90
OPEN PRICE ( ) 350.00
BID PRICE (QTY) 348.50 (8)
OFFER PRICE (QTY) 351.60 (28)
VOLUME 5035
TODAY'S LOW / HIGH( ) 340.00 357.95
52 WK LOW / HIGH ( )159 470
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.